Skip to main content

Generic Vandazole Availability

Last updated on Oct 6, 2021.

Vandazole is a brand name of metronidazole topical, approved by the FDA in the following formulation(s):

VANDAZOLE (metronidazole - gel;vaginal)

  • Manufacturer: TEVA PHARMS
    Approval date: May 20, 2005
    Strength(s): 0.75% [BX]

Has a generic version of Vandazole been approved?

No. There is currently no therapeutically equivalent version of Vandazole available in the United States.

Note: Fraudulent online pharmacies may attempt to sell an illegal generic version of Vandazole. These medications may be counterfeit and potentially unsafe. If you purchase medications online, be sure you are buying from a reputable and valid online pharmacy. Ask your health care provider for advice if you are unsure about the online purchase of any medication.

See also: Generic Drug FAQ.

Related Patents

Patents are granted by the U.S. Patent and Trademark Office at any time during a drug's development and may include a wide range of claims.

  • Vaginal pharmaceutical compositions and methods for preparing them
    Patent 7,456,207
    Issued: November 25, 2008
    Inventor(s): Bentley; Christine Lynn & Feldtmose; Karen
    Assignee(s): Teva Pharmaceuticals USA, Inc.

    Vaginal pharmaceutical compositions are described. These compositions contain (i) an active pharmaceutical ingredient selected from the group consisting of antimicrobial imidazoles and mixtures thereof, and (ii) a polysaccharide, wherein the pH of the composition is greater than 4.25 and less than about 8. In particularly preferred compositions, the active pharmaceutical ingredient includes metronidazole and the polysaccharide includes hypromellose. These compositions can be applied to vaginal tissue for treatment of various diseases, such as bacterial vaginosis, or for prophylaxis.

    Patent expiration dates:

    • September 22, 2024
      ✓ 
      Drug product

Glossary

Term Definition
Drug Patent A drug patent is assigned by the U.S. Patent and Trademark Office and assigns exclusive legal right to the patent holder to protect the proprietary chemical formulation. The patent assigns exclusive legal right to the inventor or patent holder, and may include entities such as the drug brand name, trademark, product dosage form, ingredient formulation, or manufacturing process A patent usually expires 20 years from the date of filing, but can be variable based on many factors, including development of new formulations of the original chemical, and patent infringement litigation.
Drug Exclusivity Exclusivity is the sole marketing rights granted by the FDA to a manufacturer upon the approval of a drug and may run simultaneously with a patent. Exclusivity periods can run from 180 days to seven years depending upon the circumstance of the exclusivity grant.

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.